|9th February 2021||Jack Y. Zhang||11,927||Open or private sale||$18.93||$225,775.72|
|8th February 2021||Jack Y. Zhang||13,452||Open or private sale||$18.89||$254,049.09|
|5th February 2021||Jack Y. Zhang||15,507||Open or private sale||$18.94||$293,721.19|
|4th February 2021||Jack Y. Zhang||25,570||Open or private sale||$18.89||$483,019.86|
|3rd February 2021||Jack Y. Zhang||16,299||Open or private sale||$18.36||$299,322.99|
|2nd February 2021||Jack Y. Zhang||13,817||Open or private sale||$18.66||$257,821.07|
|1st February 2021||Floyd F. Petersen||639||Open or private sale||$18.26||$11,668.91|
|1st February 2021||Jack Y. Zhang||24,114||Open or private sale||$18.29||$441,119.81|
|19th January 2021||William J Peters||6,495||Open or private sale||$18.67||$121,236.97|
|1st December 2020||Richard K Prins||50,000||Open or private sale||$2.04||$102,000.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.